Advanced Treatments for Macular Degeneration: PBM Therapy Explained

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over the age of 50. While this condition can significantly impact daily life, advancements in eye care are creating new opportunities to manage the disease and help preserve vision. One of the most promising developments is Photobiomodulation (PBM) therapy, an innovative treatment designed to support retinal health in patients with dry macular degeneration.

At Eye Care Associates, we are proud to be the only practice in the area offering this advanced treatment, giving patients access to cutting-edge technology designed to help protect their vision.

Understanding Macular Degeneration

Macular degeneration is a progressive eye condition that affects the macula, the central portion of the retina responsible for sharp, detailed vision. The macula allows us to perform tasks that require precision, such as reading, recognizing faces, and driving.

There are two main forms of AMD:

  • Dry AMD: This is the most common type, accounting for roughly 80-90% of cases. It develops gradually as the macula becomes thinner and deposits called drusen accumulate under the retina.
  • Wet AMD: This less common but more severe form occurs when abnormal blood vessels grow under the retina and leak fluid or blood, causing rapid damage.

Although there is currently no cure for macular degeneration, early detection and modern treatment options can help slow progression and protect remaining vision.

What Is PBM Therapy?

Photobiomodulation (PBM) therapy is a light-based treatment designed to stimulate retinal cells and improve their function. The therapy uses carefully controlled wavelengths of red, yellow, and near-infrared light that pass through the layers of the retina.

These therapeutic light wavelengths activate the mitochondria within retinal cells. Mitochondria act as the energy generators of the cell, and when they function more efficiently, they can better support the health of critical retinal structures such as the retinal pigment epithelium and photoreceptor cells, both of which play an essential role in maintaining clear vision.

PBM therapy is:

  • Non-invasive
  • Drug-free
  • Painless
  • Quick to administer

While PBM therapy does not cure macular degeneration, research suggests it may help slow disease progression, support retinal cell function, and in some cases improve visual performance for patients with dry AMD.

Benefits of PBM Therapy

Studies investigating PBM therapy for dry AMD have shown encouraging results. Potential benefits may include:

  • Improved or stabilized vision: Some patients experience improvements in visual clarity or stabilization of vision that might otherwise decline.
  • Enhanced cellular energy production: By stimulating mitochondrial activity, PBM may help retinal cells function more efficiently and maintain healthier tissue.
  • Support against disease progression: PBM therapy may help slow structural changes in the retina, including the development of geographic atrophy, an advanced stage of dry AMD.

The greatest benefits appear to occur when treatment begins during the mild to moderate stages of dry macular degeneration, before extensive retinal damage has developed.

Why Early Detection Matters

Because dry AMD develops gradually, many people may not notice symptoms in the early stages. However, early intervention often provides the best opportunity to slow progression and protect vision.

Regular eye exams allow our eye doctors to monitor retinal health and detect subtle changes before vision is significantly affected. If AMD is identified early, therapies like PBM may offer meaningful support in maintaining visual function.

Experience Advanced AMD Care at Eye Care Associates

At Eye Care Associates, we are committed to offering the most advanced technologies for protecting and preserving your vision. As the only practice providing Photobiomodulation therapy for dry macular degeneration, we are proud to deliver innovative care that may help patients manage AMD more effectively. Our team carefully evaluates each patient’s retinal health to determine whether PBM therapy may be an appropriate part of their treatment plan.

Schedule a consultation with Eye Care Associates to learn whether PBM therapy may be right for managing AMD and take a proactive step toward protecting your vision. Contact our office in Flagstaff, Arizona, by calling (928) 774-7949 to book an appointment today.